| Year |
Citation |
Score |
| 2024 |
Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, ... ... Bansal MB, et al. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. The New England Journal of Medicine. 390: 497-509. PMID 38324483 DOI: 10.1056/NEJMoa2309000 |
0.35 |
|
| 2023 |
Harrison SA, Ratziu V, Anstee QM, Noureddin M, Sanyal AJ, Schattenberg JM, Bedossa P, Bashir MR, Schneider D, Taub R, Bansal M, Kowdley KV, Younossi ZM, Loomba R. Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis. Alimentary Pharmacology & Therapeutics. PMID 37786277 DOI: 10.1111/apt.17734 |
0.333 |
|
| 2023 |
Karim G, Bansal MB. Resmetirom: An Orally Administered, Smallmolecule, Liver-directed, β-selective THR Agonist for the Treatment of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis. Touchreviews in Endocrinology. 19: 60-70. PMID 37313239 DOI: 10.17925/EE.2023.19.1.60 |
0.333 |
|
| 2020 |
Zhang L, Bansal MB. Role of Kupffer Cells in Driving Hepatic Inflammation and Fibrosis in HIV Infection. Frontiers in Immunology. 11: 1086. PMID 32612603 DOI: 10.3389/Fimmu.2020.01086 |
0.562 |
|
| 2019 |
Harrison SA, Bashir MR, Guy CD, Zhou R, Moylan CA, Frias JP, Alkhouri N, Bansal MB, Baum S, Neuschwander-Tetri BA, Taub R, Moussa SE. Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet (London, England). PMID 31727409 DOI: 10.1016/S0140-6736(19)32517-6 |
0.427 |
|
| 2019 |
Zhang L, Mosoian A, Schwartz ME, Florman SS, Gunasekaran G, Schiano T, Fiel MI, Jiang W, Shen Q, Branch AD, Bansal MB. HIV infection modulates IL-1β response to LPS stimulation through a TLR4-NLRP3 pathway in human liver macrophages. Journal of Leukocyte Biology. PMID 30776150 DOI: 10.1002/Jlb.4A1018-381R |
0.495 |
|
| 2019 |
Bansal MB, Chamroonkul N. Correction to: Antifibrotics in liver disease: are we getting closer to clinical use? Hepatology International. PMID 30697679 DOI: 10.1007/S12072-018-09924-1 |
0.375 |
|
| 2019 |
Mei R, Bansal MB, Kushner T. Su1512 – Lower Adherence to Hepatitis B Pregnancy Cascade of Care Among “Low-Risk” Groups Gastroenterology. 156: S-1290. DOI: 10.1016/S0016-5085(19)40227-8 |
0.3 |
|
| 2018 |
Chamroonkul N, Bansal MB. HIV and the liver. Nature Reviews. Gastroenterology & Hepatology. PMID 30413781 DOI: 10.1038/S41575-018-0085-7 |
0.501 |
|
| 2018 |
Bansal MB, Chamroonkul N. Antifibrotics in liver disease: are we getting closer to clinical use? Hepatology International. PMID 30302735 DOI: 10.1007/S12072-018-9897-3 |
0.504 |
|
| 2018 |
Volk M, Mellinger J, Bansal MB, Gellad ZF, McClellan M, Kanwal F. A Roadmap for Value-Based Payment Models among Patients with Cirrhosis. Hepatology (Baltimore, Md.). PMID 30226642 DOI: 10.1002/Hep.30277 |
0.38 |
|
| 2018 |
Harrison S, Moussa S, Bashir M, Alkhouri N, Frias J, Baum S, Tetri B, Bansal M, Taub R. MGL-3196, a selective thyroid hormone receptor-beta agonist significantly decreases hepatic fat in NASH patients at 12 weeks, the primary endpoint in a 36 week serial liver biopsy study Journal of Hepatology. 68. DOI: 10.1016/S0168-8278(18)30292-7 |
0.4 |
|
| 2017 |
Bichoupan K, Tandon N, Crismale JF, Hartman J, Del Bello D, Patel N, Chekuri S, Harty A, Ng M, Sigel KM, Bansal MB, Grewal P, Chang CY, Leong J, Im GY, et al. Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results. World Journal of Virology. 6: 59-72. PMID 29147645 DOI: 10.5501/Wjv.V6.I4.59 |
0.384 |
|
| 2016 |
Mosoian A, Zhang L, Hong F, Cunyat F, Rahman A, Bhalla R, Panchal A, Saiman Y, Fiel MI, Florman S, Roayaie S, Schwartz M, Branch A, Stevenson M, Bansal MB. HIV infection of Kupffer cells results in an amplified proinflammatory response to LPS. Journal of Leukocyte Biology. PMID 27986871 DOI: 10.1189/Jlb.3Hi0516-242R |
0.722 |
|
| 2016 |
Rockstroh JK, Plonski F, Bansal M, Fätkenheuer G, Small CB, Asmuth DM, Pialoux G, Zhang-Roper R, Wang R, Pineda JA, Heera J. Hepatic safety of maraviroc in patients with HIV-1 and hepatitis C and/or B virus: 144-week results from a randomized, placebo-controlled trial. Antiviral Therapy. PMID 27924779 DOI: 10.3851/Imp3116 |
0.464 |
|
| 2016 |
Crismale JF, Stueck A, Bansal M. Toxin-Induced Autoimmune Hepatitis Caused by Raw Cashew Nuts. Acg Case Reports Journal. 3: e133. PMID 27807585 DOI: 10.14309/Crj.2016.106 |
0.439 |
|
| 2016 |
Klepper A, Eng FJ, Doyle EH, El-Shamy A, Rahman AH, Fiel MI, Avino GC, Lee M, Ye F, Roayaie S, Bansal MB, MacDonald MR, Schiano TD, Branch AD. Hepatitis C virus double-stranded RNA is the predominant form in human liver and in interferon-treated cells. Hepatology (Baltimore, Md.). PMID 27642141 DOI: 10.1002/Hep.28846 |
0.355 |
|
| 2016 |
Bansal MB. Hepatic stellate cells: fibrogenic, regenerative or both? Heterogeneity and context are key. Hepatology International. PMID 27578210 DOI: 10.1007/S12072-016-9758-X |
0.488 |
|
| 2016 |
Jiao J, Ooka K, Fey H, Fiel MI, Rahmman AH, Kojima K, Hoshida Y, Chen X, Paula T, Vetter D, Sastre D, Lee KH, Lee Y, Bansal M, Friedman SL, et al. Interleukin-15 Receptor α on Hepatic Stellate Cells Controls Fibrogenesis In Murine Liver Injury. Journal of Hepatology. PMID 27154062 DOI: 10.1016/J.Jhep.2016.04.020 |
0.437 |
|
| 2016 |
Patel N, Bichoupan K, Ku L, Yalamanchili R, Harty A, Gardenier D, Ng M, Motamed D, Khaitova V, Bach N, Chang C, Grewal P, Bansal M, Agarwal R, Liu L, et al. Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus. World Journal of Gastroenterology. 22: 2844-54. PMID 26973423 DOI: 10.3748/Wjg.V22.I9.2844 |
0.444 |
|
| 2015 |
Rockstroch JK, Soriano V, Plonski F, Bansal M, Fätkenheuer G, Small CB, Asmuth DM, Pialoux G, Mukwaya G, Jagannatha S, Heera J, Pineda JA. Corrigendum. Hepatic Safety in Subjects With HIV-1 and Hepatitis C and/or B Virus: A Randomised, Double-Blind Study of Maraviroc vs Placebo in Combination With Antiretroviral Agents. Hiv Clinical Trials. 16: 236-7. PMID 26777796 DOI: 10.1080/15284336.2015.1124625 |
0.338 |
|
| 2015 |
Saiman Y, Sugiyama T, Simchoni N, Spirli C, Bansal MB. Biliary Epithelial Cells Are Not the Predominant Source of Hepatic CXCL12. The American Journal of Pathology. 185: 1859-66. PMID 25934614 DOI: 10.1016/J.Ajpath.2015.03.006 |
0.736 |
|
| 2015 |
Rockstroh JK, Soriano V, Plonski F, Bansal M, Fätkenheuer G, Small CB, Asmuth DM, Pialoux G, Mukwaya G, Jagannatha S, Heera J, Pineda JA. Hepatic safety in subjects with HIV-1 and hepatitis C and/or B virus: a randomized, double-blind study of maraviroc versus placebo in combination with antiretroviral agents. Hiv Clinical Trials. 16: 72-80. PMID 25923596 DOI: 10.1179/1528433614Z.0000000011 |
0.405 |
|
| 2015 |
Saiman Y, Jiao J, Fiel MI, Friedman SL, Aloman C, Bansal MB. Inhibition of the CXCL12/CXCR4 chemokine axis with AMD3100, a CXCR4 small molecule inhibitor, worsens murine hepatic injury. Hepatology Research : the Official Journal of the Japan Society of Hepatology. 45: 794-803. PMID 25163538 DOI: 10.1111/Hepr.12411 |
0.739 |
|
| 2014 |
Sefcik RK, Bichoupan K, Martel-Laferrière V, Odin JA, Liu LU, Perumalswami P, Bansal M, Dieterich DT, Ahmad J, Schiano TD, Branch AD. Telaprevir activity in treatment-naive patients infected with hepatitis C virus genotype 4. The Journal of Infectious Diseases. 210: 1855-6. PMID 24970848 DOI: 10.1093/Infdis/Jiu360 |
0.381 |
|
| 2014 |
Bichoupan K, Schwartz JM, Martel-Laferriere V, Giannattasio ER, Marfo K, Odin JA, Liu LU, Schiano TD, Perumalswami P, Bansal M, Gaglio PJ, Kalia H, Dieterich DT, Branch AD, Reinus JF. Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir. Alimentary Pharmacology & Therapeutics. 39: 209-16. PMID 24266536 DOI: 10.1111/Apt.12560 |
0.326 |
|
| 2014 |
Crismale JF, Martel-Laferrière V, Bichoupan K, Schonfeld E, Pappas A, Wyatt C, Odin JA, Liu LU, Schiano TD, Perumalswami PV, Bansal M, Dieterich DT, Branch AD. Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy. Liver International : Official Journal of the International Association For the Study of the Liver. 34: 1018-24. PMID 24118693 DOI: 10.1111/Liv.12342 |
0.389 |
|
| 2013 |
Saiman Y, Agarwal R, Hickman DA, Fausther M, El-Shamy A, Dranoff JA, Friedman SL, Bansal MB. CXCL12 induces hepatic stellate cell contraction through a calcium-independent pathway. American Journal of Physiology. Gastrointestinal and Liver Physiology. 305: G375-82. PMID 23812037 DOI: 10.1152/Ajpgi.00185.2012 |
0.73 |
|
| 2012 |
Fausther M, Sheung N, Saiman Y, Bansal MB, Dranoff JA. Activated hepatic stellate cells upregulate transcription of ecto-5'-nucleotidase/CD73 via specific SP1 and SMAD promoter elements. American Journal of Physiology. Gastrointestinal and Liver Physiology. 303: G904-14. PMID 22899823 DOI: 10.1152/Ajpgi.00015.2012 |
0.718 |
|
| 2012 |
Hong F, Saiman Y, Si C, Mosoian A, Bansal MB. X4 Human immunodeficiency virus type 1 gp120 promotes human hepatic stellate cell activation and collagen I expression through interactions with CXCR4. Plos One. 7: e33659. PMID 22479424 DOI: 10.1371/Journal.Pone.0033659 |
0.741 |
|
| 2012 |
Bansal MB, Blackard JT. Effects of HIV on liver cell populations Hiv and Liver Disease. 81-90. DOI: 10.1007/9781441917126_9 |
0.383 |
|
| 2011 |
Radbill BD, Gupta R, Ramirez MC, DiFeo A, Martignetti JA, Alvarez CE, Friedman SL, Narla G, Vrabie R, Bowles R, Saiman Y, Bansal MB. Loss of matrix metalloproteinase-2 amplifies murine toxin-induced liver fibrosis by upregulating collagen I expression. Digestive Diseases and Sciences. 56: 406-16. PMID 20563750 DOI: 10.1007/S10620-010-1296-0 |
0.732 |
|
| 2010 |
Tuyama AC, Hong F, Saiman Y, Wang C, Ozkok D, Mosoian A, Chen P, Chen BK, Klotman ME, Bansal MB. Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis. Hepatology (Baltimore, Md.). 52: 612-22. PMID 20683959 DOI: 10.1002/Hep.23679 |
0.741 |
|
| 2009 |
Hong F, Tuyama A, Lee TF, Loke J, Agarwal R, Cheng X, Garg A, Fiel MI, Schwartz M, Walewski J, Branch A, Schecter AD, Bansal MB. Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation. Hepatology (Baltimore, Md.). 49: 2055-67. PMID 19434726 DOI: 10.1002/Hep.22890 |
0.481 |
|
| 2006 |
Friedman SL, Bansal MB. Reversal of hepatic fibrosis -- fact or fantasy? Hepatology (Baltimore, Md.). 43: S82-8. PMID 16447275 DOI: 10.1002/Hep.20974 |
0.473 |
|
| 2006 |
Kodali R, Hajjou M, Berman AB, Bansal MB, Zhang S, Pan JJ, Schecter AD. Chemokines induce matrix metalloproteinase-2 through activation of epidermal growth factor receptor in arterial smooth muscle cells. Cardiovascular Research. 69: 706-15. PMID 16343467 DOI: 10.1016/J.Cardiores.2005.09.012 |
0.335 |
|
| 2005 |
Bansal MB, Kovalovich K, Gupta R, Li W, Agarwal A, Radbill B, Alvarez CE, Safadi R, Fiel MI, Friedman SL, Taub RA. Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression. Journal of Hepatology. 42: 548-56. PMID 15763341 DOI: 10.1016/J.Jhep.2004.11.043 |
0.442 |
|
| 2004 |
Safadi R, Ohta M, Alvarez CE, Fiel MI, Bansal M, Mehal WZ, Friedman SL. Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes. Gastroenterology. 127: 870-82. PMID 15362042 DOI: 10.1053/J.Gastro.2004.04.062 |
0.446 |
|
| 2002 |
Bansal MB, Friedman SL. The enlarging role of matrix metalloproteinases in liver injury – beyond scar degradation Journal of Hepatology. 37: 293-294. DOI: 10.1016/S0168-8278(02)00201-5 |
0.412 |
|
| Show low-probability matches. |